Pasar al contenido principal

EFECTO DEL TRATAMIENTO CON VESICULAS EXTRACELULARES DE CELULAS MADRE DE GRASA DE RATONES JOVENES SOBRE PARAMETROS DE ENVEJECIMIENTO Y FRAGILIDAD EN RATONES DE EDAD AVANZADA

PID2020-113839RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSITAT DE VALÈNCIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Assessment and risk prediction of frailty using texture-based muscle ultrasound image analysis and machine learning techniques

  • Mirón-Mombiela, Rebeca
  • Ruiz-España, Silvia
  • Borrás, Consuelo
  • Moratal, David|||0000-0002-2825-3646
[EN] The purpose of this study was to evaluate texture-based muscle ultrasound image analysis for the assessment and risk prediction of frailty phenotype. This retrospective study of prospectively acquired data included 101 participants who underwent ultrasound scanning of the anterior thigh. Participants were subdivided according to frailty phenotype and were followed up for two years. Primary and secondary outcome measures were death and comorbidity, respectively. Forty-three texture features were computed from the rectus femoris and the vastus intermedius muscles using statistical methods. Model performance was evaluated by computing the area under the receiver operating characteristic curve (AUC) while outcome prediction was evaluated using regression analysis. Models developed achieved a moderate to good AUC (0.67 <= AUC <= 0.79) for categorizing frailty. The stepwise multiple logistic regression analysis demonstrated that they correctly classified 70-87% of the cases. The models were associated with increased comorbidity (0.01 <= p <= 0.18) and were predictive of death for pre-frail and frail participants (0.001 <= p <= 0.016). In conclusion, texture analysis can be useful to identify frailty and assess risk prediction (i.e. mortality) using texture features extracted from muscle ultrasound images in combination with a machine learning approach., This work was supported by the following grants: Grant PID2020-113839RB-I00 funded by MCIN/AEI/10.13039/501100011033 to C.B. DM acknowledges financial support from the Conselleria d ' Educacio, Investigacio, Cultura i Esport, Generalitat Valenciana (grants AEST/2018/021 and AEST/2019/037) .
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Genistein effect on cognition in prodromal Alzheimer's disease patients. The GENIAL clinical trial

  • José, Viña
  • Escudero, Joaquín
  • Baquero, Miquel
  • Cebrián, Mónica
  • Carbonell Asíns, Juan Antonio
  • Muñoz, José Enrique
  • Satorres, Encarnación
  • Meléndez, Juan Carlos
  • Ferrer Rebolleda, José
  • Cózar Santiago, Mª Del Puig
  • Santabárbara Gómez, Jose Manuel
  • Jové Font, Mariona
  • Pamplona Gras, Reinald
  • Tarazona Santabalbina, Francisco José
  • Borrás, Consuelo
Background: Delaying the transition from minimal cognitive impairment to Alzheimer’s dementia is a major concern in Alzheimer’s disease (AD) therapeutics. Pathological signs of AD occur years before the onset of clinical dementia. Thus, long-term therapeutic approaches, with safe, minimally invasive, and yet efective substances are recommended. There is a need to develop new drugs to delay Alzheimer’s dementia. We have taken a nutritional supplement approach with genistein, a chemically defned polyphenol that acts by multimodal specifc mechanisms. Our group previously showed that genistein supplementation is efective to treat the double transgenic (APP/PS1) AD animal model. Methods: In this double-blind, placebo-controlled, bicentric clinical trial, we evaluated the efect of daily oral supplementation with 120 mg of genistein for 12 months on 24 prodromal Alzheimer’s disease patients. The amyloidbeta deposition was analyzed using 18F-futemetamol uptake. We used a battery of validated neurocognitive tests: Mini-Mental State Exam (MMSE), Memory Alteration Test (M@T), Clock Drawing Test, Complutense Verbal Learning Test (TAVEC), Barcelona Test-Revised (TBR), and Rey Complex Figure Test. Results: We report that genistein treatment results in a signifcant improvement in two of the tests used (dichotomized direct TAVEC, p=0.031; dichotomized delayed Centil REY copy p=0.002 and a tendency to improve in all the rest of them. The amyloid-beta deposition analysis showed that genistein-treated patients did not increase their uptake in the anterior cingulate gyrus after treatment (p=0.878), while placebo-treated did increase it (p=0.036). We did not observe signifcant changes in other brain areas studied. Conclusions: This study shows that genistein may have a role in therapeutics to delay the onset of Alzheimer’s dementia in patients with prodromal Alzheimer’s disease. These encouraging results indicate that this should be followed up by a new study with more patients to further validate the conclusion that arises from this study., This work was supported by the following grants: CB16/10/00435 (CIBERFES) from Instituto de Salud Carlos III, (PID2019-110906RB-I00/ AEI/10.13039/501100011033) and RED2018-102576-T from the Spanish Ministry of Innovation and Science, PROMETEO/2019/097 from “Consellería de Innovación, Universidades, Ciencia y Sociedad Digital de la Generalitat Valen ciana” and EU Funded H2020- DIABFRAIL-LATAM (Ref: 825546), European Joint Programming Initiative “A Healthy Diet for a Healthy Life” (JPI HDHL) and of the ERA-NET Cofund ERA-HDHL (GA N° 696295 of the EU Horizon 2020 Research and Innovation Programme) and Fundación Ramón Areces y Fundación Soria Melguizo. to J.V. and Grant PID2020-113839RB-I00 funded by MCIN/ AEI/10.13039/501100011033, PCIN-2017-117 of the Ministry of Economy and Competitiveness, and the EU Joint Programming Initiative ‘A Healthy Diet for a Healthy Life’ (JPI HDHL INTIMIC-085) to CB. We also acknowledge funding from the Spanish Ministry of Science, Innovation, and Universities (RTI2018099200-B-I00), the Generalitat of Catalonia, Agency for management of University and Research Grants (2017SGR696) and the Department of Health (SLT002/16/00250) to RP. Part of the equipment employed in this work has been funded by Generalitat Valenciana and co-fnanced with ERDF funds (OP ERDF of Comunitat Valenciana 2014-2020). M.J. is a “Serra Hunter” Fellow.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Phenotypic upregulation of hexocylceramides and ether-linked phosphocholines as markers of human extreme longevity

  • Fernández Bernal, Anna
  • Sol, Joaquim
  • Galo-Licona, José Daniel
  • Mota Martorell, Natàlia
  • Mas-Bargues, Cristina
  • Belenguer-Varea, Ángel
  • Obis Monné, Èlia
  • Viña Ribes, José
  • Borrás, Consuelo
  • Jové Font, Mariona
  • Pamplona Gras, Reinald
Centenarians and their relatives possess a notable survival advantage, with higher longevity and reduced susceptibility to major age-related diseases. To date, characteristic omics profiles of centenarians have been described, demonstrating that these individuals with exceptional longevity regulate their metabolism to adapt and incorporate more resilient biomolecules into their cells. Among these adaptations, the lipidomic profile stands out. However, it has not yet been determined whether this lipidomic profile is specific to centenarians or is the consequence of extreme longevity genetics and is also present in centenarians' offspring. This distinction is crucial for defining potential therapeutic targets that could help delay the aging process and associated pathologies. We applied mass-spectrometry-based techniques to quantify 569 lipid species in plasma samples from 39 centenarians, 63 centenarians' offspring, and 69 noncentenarians' offspring without familial connections. Based on this profile, we calculated different indexes to characterize the functional and structural properties of plasma lipidome. Our findings demonstrate that extreme longevity genetics (centenarians and centenarians' offspring) determines a specific lipidomic signature characterized by (i) an enrichment of hexosylceramides, (ii) a decrease of specific species of ceramides and sulfatides, (iii) a global increase of ether-PC and ether-LPC, and (iv) changes in the fluidity and diversity of specific lipid classes. We point out the conversion of ceramides to hexosylceramides and the maintenance of the levels of the ether-linked PC as a phenotypic trait to guarantee extreme longevity. We propose that this molecular signature is the result of an intrinsic adaptive program that preserves protective mechanisms and cellular identity., Ministerio de Ciencia y Tecnología, Grant/Award Number: PID2020-113839RB-I00 and PID2023-152233OB-I00; Diputació de Lleida, Grant/Award Number:PP10605-PIRS2021 and PP10845-PIRS2023; Instituto de Salud Carlos III,Grant/Award Number: AC20/00026,CB16/10/00435 (CIBERFES) and PI24/01431; Conselleria d'Educació,Investigació, Cultura i Esport, Grant/Award Number: CIAICO/2022/190; Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya, Grant/Award Number: 2021SGR00990; Horizon 2020 Framework Programme, Grant/Award Number: 696295 and 825546
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Lifelong soya consumption in males does not increase lifespan but increases health span under a metabolic stress such as type 2 diabetes mellitus

  • Borrás, Consuelo
  • Abdelaziz, Kheira M.
  • Díaz, Ana
  • Gambini,Juan
  • Jové Font, Mariona
  • López-Grueso, Raul
  • Mas-Bargues, Cristina
  • Monleón, Daniel
  • Pamplona Gras, Reinald
  • Viña Ribes, José
Soya consumption can decrease oxidative stress in animal models. Moreover, phytoestrogens such as genistein, present in soya, can mimic some of the beneficial effects of estrogens and are devoid of significant side effects, such as cancer. In this study, we have performed a controlled lifelong study with male OF1 mice that consumed either a soya-free diet or a soya-rich diet. We show that, although we found an increase in the expression and activity of antioxidant enzymes in soya-consuming mice, it did not increase lifespan. We reasoned that the soya diet could not increase lifespan in a very healthy population, but perhaps it could extend health span in stressed animals such as type 2 diabetic Goto Kakizaki (GK) rats. Indeed, this was the case: we found that male GK rats consuming a soya-rich diet developed the disease at a lower rate and, therefore, lived longer than soya-free dietconsuming rats., This work was supported by the following grants: CB16/10/00435 (CIBERFES) from Instituto de Salud Carlos III, (PID2019-110906RBI00/AEI/10.13039/501100011033) and RED2018-102576-T from the Spanish Ministry of Innovation and Science, PROMETEO/2019/097 from “Consellería, de Sanitat de la Generalitat Valenciana” and EU Funded H2020- DIABFRAIL-LATAM (Ref: 825546), European Joint Programming Initiative “A Healthy Diet for a Healthy Life” (JPI HDHL) and of the ERA-NET Cofund ERA-HDHL (GA N◦ 696295 of the EU Horizon 2020 Research and Innovation Programme) to J.V. and PID2020-113839RB-I00 of the Ministry of Science and Innovation, PCIN-2017-117 of the Ministry of Economy and Competitiveness, the EU Joint Programming Initiative ‘A Healthy Diet for a Healthy Life’ (JPI HDHL INTIMIC-085) to C.B. Part of the equipment employed in this work has been funded by Generalitat Valenciana and co-financed with ERDF funds (OP ERDF of Comunitat Valenciana 2014-2020)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A mild increase in nutrient signaling to mTORC1 in mice leads to parenchymal damage, myeloid inflammation and shortened lifespan

  • Ortega-Molina, Ana
  • Lebrero-Fernández, Cristina
  • Sanz, Alba
  • Calvo-Rubio, Miguel
  • Deleyto-Seldas, Nerea
  • de Prado-Rivas, Lucía
  • Plata-Gómez, Ana Belén
  • Fernández-Florido, Elena
  • González-García, Patricia
  • Vivas-García, Yurena
  • Sánchez García, Elena
  • Graña-Castro, Osvaldo
  • Price, Nathan L
  • Aroca-Crevillén, Alejandra
  • Caleiras, Eduardo
  • Monleón, Daniel
  • Borrás, Consuelo
  • Casanova-Acebes, María
  • de Cabo, Rafael
  • Efeyan, Alejo
The mechanistic target of rapamycin complex 1 controls cellular anabolism in response to growth factor signaling and to nutrient sufficiency signaled through the Rag GTPases. Inhibition of mTOR reproducibly extends longevity across eukaryotes. Here we report that mice that endogenously express active mutant variants of RagC exhibit multiple features of parenchymal damage that include senescence, expression of inflammatory molecules, increased myeloid inflammation with extensive features of inflammaging and a ~30% reduction in lifespan. Through bone marrow transplantation experiments, we show that myeloid cells are abnormally activated by signals emanating from dysfunctional RagC-mutant parenchyma, causing neutrophil extravasation that inflicts additional inflammatory damage. Therapeutic suppression of myeloid inflammation in aged RagC-mutant mice attenuates parenchymal damage and extends survival. Together, our findings link mildly increased nutrient signaling to limited lifespan in mammals, and support a two-component process of parenchymal damage and myeloid inflammation that together precipitate a time-dependent organ deterioration that limits longevity., ERC-2014-STG-638891/EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) LCF/PR/HR21/0046/"la Caixa" Foundation (Caixa Foundation) ID 100010434 LCF/BQ/DR19/11740022/"la Caixa" Foundation (Caixa Foundation) LABAE16001EFEY/AECC/Fundación Científica Asociación Española Contra el Cáncer (Scientific Foundation, Spanish Association Against Cancer) Research was supported by the RETOS projects Programme of Spanish Ministry of Science,Innovation and Universities, Spanish State Research Agency, co-funded by the European Regional Development Fund (grants PID2019-104012RB-I00 and PID2022-136413OB-I00), EU-H2020 Programme (ERC-2014-STG-638891), a Ramon y Cajal Award from MICIU/AEI (RYC-2013-13546) C.B. and D.M. acknowledge grant PID2020-113839RB-I00 funded by MCIN/AEI/10.13039/501100011033 and grant PID2019-108973RB-C22 funded by MCIN/AEI/10.13039/501100011033, respectively E.F.F. is a PIPF-2022/SAL-GL-24382 fellow from the Autonomous Community of Madrid
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Lifelong soya consumption in males does not increase lifespan but increases health span under a metabolic stress such as type 2 diabetes mellitus

  • Borrás, Consuelo
  • Abdelaziz, Kheira M.
  • Díaz, Ana
  • Gambini,Juan
  • Jové Font, Mariona
  • López-Grueso, Raul
  • Mas-Bargues, Cristina
  • Monleón, Daniel
  • Pamplona Gras, Reinald
  • Viña Ribes, José
Soya consumption can decrease oxidative stress in animal models. Moreover, phytoestrogens such as genistein, present in soya, can mimic some of the beneficial effects of estrogens and are devoid of significant side effects, such as cancer. In this study, we have performed a controlled lifelong study with male OF1 mice that consumed either a soya-free diet or a soya-rich diet. We show that, although we found an increase in the expression and activity of antioxidant enzymes in soya-consuming mice, it did not increase lifespan. We reasoned that the soya diet could not increase lifespan in a very healthy population, but perhaps it could extend health span in stressed animals such as type 2 diabetic Goto Kakizaki (GK) rats. Indeed, this was the case: we found that male GK rats consuming a soya-rich diet developed the disease at a lower rate and, therefore, lived longer than soya-free dietconsuming rats., This work was supported by the following grants: CB16/10/00435 (CIBERFES) from Instituto de Salud Carlos III, (PID2019-110906RBI00/AEI/10.13039/501100011033) and RED2018-102576-T from the Spanish Ministry of Innovation and Science, PROMETEO/2019/097 from “Consellería, de Sanitat de la Generalitat Valenciana” and EU Funded H2020- DIABFRAIL-LATAM (Ref: 825546), European Joint Programming Initiative “A Healthy Diet for a Healthy Life” (JPI HDHL) and of the ERA-NET Cofund ERA-HDHL (GA N◦ 696295 of the EU Horizon 2020 Research and Innovation Programme) to J.V. and PID2020-113839RB-I00 of the Ministry of Science and Innovation, PCIN-2017-117 of the Ministry of Economy and Competitiveness, the EU Joint Programming Initiative ‘A Healthy Diet for a Healthy Life’ (JPI HDHL INTIMIC-085) to C.B. Part of the equipment employed in this work has been funded by Generalitat Valenciana and co-financed with ERDF funds (OP ERDF of Comunitat Valenciana 2014-2020)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Phenotypic upregulation of hexocylceramides and ether-linked phosphocholines as markers of human extreme longevity

  • Fernández Bernal, Anna
  • Sol, Joaquim
  • Galo-Licona, José Daniel
  • Mota Martorell, Natàlia
  • Mas-Bargues, Cristina
  • Belenguer-Varea, Ángel
  • Obis Monné, Èlia
  • Viña Ribes, José
  • Borrás, Consuelo
  • Jové Font, Mariona
  • Pamplona Gras, Reinald
Centenarians and their relatives possess a notable survival advantage, with higher longevity and reduced susceptibility to major age-related diseases. To date, characteristic omics profiles of centenarians have been described, demonstrating that these individuals with exceptional longevity regulate their metabolism to adapt and incorporate more resilient biomolecules into their cells. Among these adaptations, the lipidomic profile stands out. However, it has not yet been determined whether this lipidomic profile is specific to centenarians or is the consequence of extreme longevity genetics and is also present in centenarians' offspring. This distinction is crucial for defining potential therapeutic targets that could help delay the aging process and associated pathologies. We applied mass-spectrometry-based techniques to quantify 569 lipid species in plasma samples from 39 centenarians, 63 centenarians' offspring, and 69 noncentenarians' offspring without familial connections. Based on this profile, we calculated different indexes to characterize the functional and structural properties of plasma lipidome. Our findings demonstrate that extreme longevity genetics (centenarians and centenarians' offspring) determines a specific lipidomic signature characterized by (i) an enrichment of hexosylceramides, (ii) a decrease of specific species of ceramides and sulfatides, (iii) a global increase of ether-PC and ether-LPC, and (iv) changes in the fluidity and diversity of specific lipid classes. We point out the conversion of ceramides to hexosylceramides and the maintenance of the levels of the ether-linked PC as a phenotypic trait to guarantee extreme longevity. We propose that this molecular signature is the result of an intrinsic adaptive program that preserves protective mechanisms and cellular identity., Ministerio de Ciencia y Tecnología, Grant/Award Number: PID2020-113839RB-I00 and PID2023-152233OB-I00; Diputació de Lleida, Grant/Award Number:PP10605-PIRS2021 and PP10845-PIRS2023; Instituto de Salud Carlos III,Grant/Award Number: AC20/00026,CB16/10/00435 (CIBERFES) and PI24/01431; Conselleria d'Educació,Investigació, Cultura i Esport, Grant/Award Number: CIAICO/2022/190; Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya, Grant/Award Number: 2021SGR00990; Horizon 2020 Framework Programme, Grant/Award Number: 696295 and 825546
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Genistein effect on cognition in prodromal Alzheimer's disease patients. The GENIAL clinical trial

  • José, Viña
  • Escudero, Joaquín
  • Baquero, Miquel
  • Cebrián, Mónica
  • Carbonell Asíns, Juan Antonio
  • Muñoz, José Enrique
  • Satorres, Encarnación
  • Meléndez, Juan Carlos
  • Ferrer Rebolleda, José
  • Cózar Santiago, Mª Del Puig
  • Santabárbara Gómez, Jose Manuel
  • Jové Font, Mariona
  • Pamplona Gras, Reinald
  • Tarazona Santabalbina, Francisco José
  • Borrás, Consuelo
Background: Delaying the transition from minimal cognitive impairment to Alzheimer’s dementia is a major concern in Alzheimer’s disease (AD) therapeutics. Pathological signs of AD occur years before the onset of clinical dementia. Thus, long-term therapeutic approaches, with safe, minimally invasive, and yet efective substances are recommended. There is a need to develop new drugs to delay Alzheimer’s dementia. We have taken a nutritional supplement approach with genistein, a chemically defned polyphenol that acts by multimodal specifc mechanisms. Our group previously showed that genistein supplementation is efective to treat the double transgenic (APP/PS1) AD animal model. Methods: In this double-blind, placebo-controlled, bicentric clinical trial, we evaluated the efect of daily oral supplementation with 120 mg of genistein for 12 months on 24 prodromal Alzheimer’s disease patients. The amyloidbeta deposition was analyzed using 18F-futemetamol uptake. We used a battery of validated neurocognitive tests: Mini-Mental State Exam (MMSE), Memory Alteration Test (M@T), Clock Drawing Test, Complutense Verbal Learning Test (TAVEC), Barcelona Test-Revised (TBR), and Rey Complex Figure Test. Results: We report that genistein treatment results in a signifcant improvement in two of the tests used (dichotomized direct TAVEC, p=0.031; dichotomized delayed Centil REY copy p=0.002 and a tendency to improve in all the rest of them. The amyloid-beta deposition analysis showed that genistein-treated patients did not increase their uptake in the anterior cingulate gyrus after treatment (p=0.878), while placebo-treated did increase it (p=0.036). We did not observe signifcant changes in other brain areas studied. Conclusions: This study shows that genistein may have a role in therapeutics to delay the onset of Alzheimer’s dementia in patients with prodromal Alzheimer’s disease. These encouraging results indicate that this should be followed up by a new study with more patients to further validate the conclusion that arises from this study., This work was supported by the following grants: CB16/10/00435 (CIBERFES) from Instituto de Salud Carlos III, (PID2019-110906RB-I00/ AEI/10.13039/501100011033) and RED2018-102576-T from the Spanish Ministry of Innovation and Science, PROMETEO/2019/097 from “Consellería de Innovación, Universidades, Ciencia y Sociedad Digital de la Generalitat Valen ciana” and EU Funded H2020- DIABFRAIL-LATAM (Ref: 825546), European Joint Programming Initiative “A Healthy Diet for a Healthy Life” (JPI HDHL) and of the ERA-NET Cofund ERA-HDHL (GA N° 696295 of the EU Horizon 2020 Research and Innovation Programme) and Fundación Ramón Areces y Fundación Soria Melguizo. to J.V. and Grant PID2020-113839RB-I00 funded by MCIN/ AEI/10.13039/501100011033, PCIN-2017-117 of the Ministry of Economy and Competitiveness, and the EU Joint Programming Initiative ‘A Healthy Diet for a Healthy Life’ (JPI HDHL INTIMIC-085) to CB. We also acknowledge funding from the Spanish Ministry of Science, Innovation, and Universities (RTI2018099200-B-I00), the Generalitat of Catalonia, Agency for management of University and Research Grants (2017SGR696) and the Department of Health (SLT002/16/00250) to RP. Part of the equipment employed in this work has been funded by Generalitat Valenciana and co-fnanced with ERDF funds (OP ERDF of Comunitat Valenciana 2014-2020). M.J. is a “Serra Hunter” Fellow.
e_Buah Biblioteca Digital Universidad de Alcalá
Publicación Artículo científico (JournalArticle)

Exploring New Kingdoms: The Role of Extracellular Vesicles in Oxi-Inflamm-Aging Related to Cardiorenal Syndrome

  • Alique Aguilar, Matilde|||0000-0002-7912-1133
The incidence of age associated chronic diseases has increased in recent years. Although several diverse causes produce these phenomena, abundant evidence shows that oxidative stress plays a central role. In recent years, numerous studies have focused on elucidating the role of oxidative stress in the development and progression of both aging and chronic diseases, opening the door to the discovery of new underlying mechanisms and signaling pathways. Among them, senolytics and senomorphics, and extracellular vesicles offer new therapeutic strategies to slow the development of aging and its associated chronic diseases by decreasing oxidative stress. In this review, we aim to discuss the role of extracellular vesicles in human cardiorenal syndrome development and their possible role as biomarkers, targets, or vehicles of drugs to treat this syndrome., Instituto de Salud Carlos III, Sociedad Española de Nefrología, Ministerio de Asuntos Económicos y Transformación Digital, Ministerio de Cultura y Deporte, Ministerio de Ciencia e Innovación, Comunidad de Madrid
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Interplay between oxidative stress and physical exercise in hospitalized older adults: a secondary analysis of an RCT using malondialdehyde as a biomarker

  • Chenhuichen, Chenhui
  • Azanon-Nogueira, Pedro
  • Izco-Cubero, Maite
  • Echeverria-Beistegui, Iciar
  • Álvarez Rodríguez, Patricia
  • Zambom Ferraresi, Fabíola
  • Zambom Ferraresi, Fabrício
  • Fernández González de la Riva, María Luisa
  • Borrás, Consuelo
  • Martínez Velilla, Nicolás
Introduction: Oxidative stress, driven by the imbalance between reactive species from oxygen and nitrogen and antioxidant defense mechanisms, plays a pivotal role in aging-related pathologies. Structured multicomponent exercise interventions have mitigated hospital-acquired disability by improving physical and cognitive function and quality of life. However, the underlying molecular mechanisms of this improvement remain partially understood. Methods: We conducted a secondary analysis of a randomized controlled trial to investigate the impact of a supervised exercise program on oxidative stress in hospitalized older adults. Participants were randomized to a 3-day tailored exercise program based on baseline functional capacity. Serum malondialdehyde (MDA) levels (μmol/mL) and the oxidative oxidation of total proteins (PO) were measured. RESULTS: Seventy-two participants were included in this subanalysis (mean age 86.8 years [SD 4.96], 53.8% female [n = 39]). The exercise group showed a minimal change in MDA levels, while the control group exhibited a significant increase, with a between-group difference of −0.24 μmol/ mL (p < 0.01). Subgroup analyses demonstrated significant benefits in patients with diabetes and in women. The intervention improved functional capacity and subjective health status. Participants with lower baseline oxidative stress levels showed greater improvement in SPPB compared to those with higher baseline levels. Discussion: Structured exercise may mitigate the increase in oxidative stress in hospitalized older adults, particularly in women and those with diabetes. The magnitude of functional improvements could depend on baseline oxidative status, highlighting the need for personalized interventions. Future research should explore long-term effects, biomarkers, and tailored protocols to optimize outcomes in this population., This research was funded by: a research grant PI17/01814 from the Ministerio de Economía, Industria y Competitividad (ISCIII, FEDER); PID 2020-113839RB-I00, and PID 2024-156346OB-I00 funded by Ministerio de Ciencia, Innovación y Universidades and CIAICO/2022/190 funded by Conselleria de Educación, Cultura, Universidades; PI-2023-004 funded by VCL-Bioclinic; and AP2024VLC-08 funded by VLC-Biomed to CB. The Generalitat Valenciana has funded part of the equipment used in this work and co-financed it with ERDF funds (OP ERDF of Comunitat Valenciana 2014-2020).